Opendata, web and dolomites

Bacticon1

BACTerial detection and CONtrol of urinary tract infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Bacticon1 project word cloud

Explore the words cloud of the Bacticon1 project. It provides you a very rough idea of what is the project "Bacticon1" about.

prototype    615    blood    place    false    benchmarking    infection    revenue    days    measuring    sales    things    547    american    portfolio    excessive    economical    acquired    die    mean    feasibility    urological    route    hospital    fact    catheter    marketing    time    efficient    nanoparticles    tech    prolonged    economic    expenses    verify    rates    suited    stream    business    asia    urinary    western    infections    option    add    approval    material    possibilities    fourth    model    dominating    patient    commercialised    innovation    death    hybrid    biosensor    market    nano    severe    markets    technological    adjust    temperature    delay    indicates    monitoring    precise    conducting    socio    sustainability    caused    bio    patients    world    pursuing    biomarkers    bacticon    care    50    faster    strategy    catheters    remaining    stays    problem    incur    company    solution    biomarker    channels    med    search    approx    detection    positives    biomodics    impregnation   

Project "Bacticon1" data sheet

The following table provides information about the project.

Coordinator
BIOMODICS APS 

Organization address
address: STENGARDS ALLE 31 A
city: KGS LYNGBY
postcode: 2800
website: www.biomodics.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website http://www.biomodics.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMODICS APS DK (KGS LYNGBY) coordinator 50˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Problem Approx. 50% of all patients with severe blood stream infections die from the infections, while the remaining 50% incur excessive socio-economic expenses from prolonged hospital stays. In fact, the fourth largest cause of death in the western world is hospital and care acquired infections, most often caused by urinary catheters. Present state-of-the-art, measuring the temperature of a patient, indicates if the patient has an infection, but with approx. 2-3 days delay, and with many possibilities for false positives (increasing temperature can mean other things than infection).

Solution The innovation, the Bacticon Catheter, is a catheter impregnation technology based on a new biosensor/biomarker principle based on biomarkers, bio-nanoparticles and nano-channels in a new hybrid material, allowing for an immediate detection. The system is an add-on to existing catheters and is therefore cost efficient and face a faster route through approval procedures, providing much more precise and real-time monitoring.

Project The project has three objectives: 1: Technological feasibility study: Verify and adjust an integrated prototype 2: User feasibility study: Verify the product need by conducting a market and user study, a product innovation strategy, partner search, feasibility of concept, benchmarking with other products and a go-to-market strategy. 3: Economical feasibility study: Analyse the economical sustainability of the product

Business model The innovation is well suited to be commercialised through the sales and marketing channels of a med-tech company, which is already established in the market place, and where the Bacticon Catheter can be integrated in the existing product portfolio of such med-tech company. BioModics is pursuing this option as priority one.

Market The dominating markets are the American market with a 547 M€ urological catheter revenue and Europe with 615 M€. Increasing growth rates are expected, especially in Asia, Europe and US.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BACTICON1" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BACTICON1" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More  

VANGUARD (2020)

New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More